Author

David Looke

Associate Professor, University of Queensland. Infectious Diseases Physician and Clinical microbiologist Princess Alexandra Hospital Woolloongabba - Cited by 4,461 - Infectious Diseases - Clinical Microbiology - Antimicrobials

Biography

Dr David Looke is currently Senior Staff Specialist in Infectious Diseases at Prince Alexandra Hospital, Brisbane and Associate Professor in the Department of Medicine, University of Queensland. Dr Looke has been a member of the Therapeutic Guidelines - Antibiotic Writing Committee since 1988; is a member of the Queensland Health Drug Advisory Committee and National Councillor and Treasurer of the Australian Society for Infectious Diseases. He has published his papers in reputed international journals.
Title
Cited by
Year
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a …
PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ...Jama 320 (10), 984-994, 2018201
542
2018
Control of fluoroquinolone resistance through successful regulation, Australia
AC Cheng, J Turnidge, P Collignon, D Looke, M Barton, T GottliebEmerging infectious diseases 18 (9), 1453, 2012201
244
2012
Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations
AR McCullough, AJ Pollack, M Plejdrup Hansen, PP Glasziou, ...Medical Journal of Australia 207 (2), 65-69, 2017201
142
2017
Experimentally Induced Blood-Stage Plasmodium vivax Infection in Healthy Volunteers
JS McCarthy, PM Griffin, S Sekuloski, AT Bright, R Rockett, D Looke, ...The Journal of infectious diseases 208 (10), 1688-1694, 2013201
100
2013
Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study
A Henderson, DL Paterson, MD Chatfield, PA Tambyah, DC Lye, PP De, ...Clinical Infectious Diseases 73 (11), e32-e3850, 2021202
84
2021
Mucormycosis in Australia: contemporary epidemiology and outcomes
KJ Kennedy, K Daveson, MA Slavin, SJ Van Hal, TC Sorrell, A Lee, ...Clinical Microbiology and Infection 22 (9), 775-781, 2016201
82
2016
Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and …
PNA Harris, NL Ben Zakour, LW Roberts, AM Wailan, HM Zowawi, ...Journal of Antimicrobial Chemotherapy 73 (3), 634-2, 2018201
64
2018
Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and …
PNA Harris, NL Ben Zakour, LW Roberts, AM Wailan, HM Zowawi, ...Journal of Antimicrobial Chemotherapy 73 (3), 634-2, 2018201
64
2018
Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease
KD Nath, JG Burel, V Shankar, AL Pritchard, M Towers, D Looke, ...International journal of chronic obstructive pulmonary disease, 51-56, 2014201
55
2014
Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia
S Subedi, DFM Looke, DA McDougall, MM Sehu, EG PlayfordInternational Journal of Infectious Diseases 30, 161-165, 2015201
45
2015
Gram-negative resistance: can we combat the coming of a new “Red Plague”?
DFM Looke, T Gottlieb, CA Jones, DL PatersonThe Medical Journal of Australia 198 (5), 243-244, 2013201
41
2013
Therapeutic drug monitoring to adjust dosing in morbid obesity–a new use for an old methodology
JH Martin, M Saleem, D LookeBritish journal of clinical pharmacology 73 (5), 685-690, 2012201
38
2012
Risk factors for urinary catheter associated bloodstream infection
EC Bursle, J Dyer, DFM Looke, DAJ McDougall, DL Paterson, ...Journal of Infection 70 (6), 585-591, 2015201
26
2015
Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
N Townell, D Looke, D McDougall, JS McCarthyMalaria Journal 11 (1), 1-7, 20101
22
2012
Bites (mammalian)
D Looke, C DendleBMJ clinical evidence 15, 151
20
2015
Should we abandon “finishing the course” of antimicrobials?
C Del Mar, DFM LookeBMJ 358, 2017201
15
2017
Death from an untreatable infection may signal the start of the post-antibiotic era
CA Jones, JS Davis, DFM LookeMed J Aust 206 (7), 292-3, 2017201
15
2017
Community-associated methicillin-resistant staphylococcus aureus endocarditis ‘down under’: case series and literature review
NJ Townell, WJ Munckhof, G Nimmo, A Bannan, A Holley, A Daniel, ...Scandinavian Journal of Infectious Diseases 44 (7), 536-540, 2012201
13
2012
Infectious diseases consultations at an A ustralian T ertiary H ospital: a review of 11 511 inpatient consultations
EC Bursle, EG Playford, DFM LookeInternal Medicine Journal 44 (10), 998-1004, 2014201
13
2014
Predictors of treatment success after periprosthetic joint infection: 24-month follow up from a multicenter prospective observational cohort study of 653 patients
JS Davis, S Metcalf, B Clark, JO Robinson, P Huggan, C Luey, S McBride, ...Open Forum Infectious Diseases 9 (3), ofac048, 2022202
13
2022

Referred From: https://scholar.google.com.au/citations?user=zV49yR0AAAAJ&hl=en

Cited by
Citations 4461
h-index 34
i10-index 58
Recommended Journals
Open Access Journals